<?xml version="1.0" encoding="UTF-8" ?>

    <journal>
    <language>en</language>
    <journal_id_issn>2008-2835</journal_id_issn>
    <journal_id_issn_online>2008-4625</journal_id_issn_online>
    <journal_id_pii></journal_id_pii>
    <journal_id_doi></journal_id_doi>
    <journal_id_isnet></journal_id_isnet>
    <journal_id_iranmedex>276</journal_id_iranmedex>
    <journal_id_magiran>5669</journal_id_magiran>
    <journal_id_sid>11181</journal_id_sid>
    <pubdate>
	    <type>gregorian</type>
	    <year>>2016</year>
	    <month>>January-March</month>
	    <day></day>
    </pubdate>
    <volume>8</volume>
    <number>1</number>
    <publish_type>online</publish_type>
    <publish_edition>1</publish_edition>
    <article_type>fulltext</article_type>
    <articleset>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed>26855732</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>Cloning and Optimization of Soluble Vascular Endothelial Growth Factor165 Expression in Escherichia coli</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;Background: Vascular Endothelial Growth Factor (VEGF) is a coordinate regulator of physiological angiogenesis during embryogenesis, skeletal growth and reproductive functions. There are several types of VEGF, including VEGF&lt;sub&gt;165&lt;/sub&gt;. VEGFs stimulate endothelial cell growth, angiogenesis, and capillary permeability. Low induction temperature is a major factor for expression of the recombinant VEGF&lt;sub&gt;165&lt;/sub&gt; in soluble form. The purpose of this study was cloning and optimization of soluble vascular endothelial growth factor165 expression in &lt;em&gt;Escherichia coli (E. coli)&lt;/em&gt;.&lt;br /&gt;
Methods: In this study, total RNA of HeLa cell [cervix epithelium] was extracted. The VEGF&lt;sub&gt;165&lt;/sub&gt; gene was amplified by reverse transcription polymerase chain reaction (RT-PCR), and then VEGF&lt;sub&gt;165&lt;/sub&gt; was subcloned into prokaryotic expression vectors pET-32a(+) and transformed into BL21 (DE3) &lt;em&gt;E. coli&lt;/em&gt; strain. VEGF&lt;sub&gt;165&lt;/sub&gt; expression was optimized by fine adjustments such as induction time and incubation temperature. VEGF&lt;sub&gt;165&lt;/sub&gt; was analyzed by DNA sequencing prior to expression and the protein was further characterized by SDS-PAGE and immunoblotting using His&amp;bull;tag specific polyclonal antibody.&lt;br /&gt;
Results: Our results demonstrated that VEGF&lt;sub&gt;165&lt;/sub&gt; was successfully cloned and expressed in pET-32a(+) vector. Optimization of the expression procedure showed that, induction by 1 &lt;em&gt;mM&lt;/em&gt; IPTG at OD600=0.7 and overnight incubation at 22&lt;sup&gt;o&lt;/sup&gt;&lt;em&gt;C&lt;/em&gt; resulted in the highest expression levels of soluble VEGF&lt;sub&gt;165&lt;/sub&gt;.&lt;br /&gt;
Conclusion: In this study, the expression of VEGF&lt;sub&gt;165&lt;/sub&gt; in a high soluble level was successfully cloned and optimized.&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Expression, Inclusion bodies, Recombinant, VEGF&lt;sub&gt;165&lt;/sub&gt; protein</keyword>
	<start_page>23</start_page>
	<end_page>28</end_page>
	<web_url>https://www.ajmb.org/En/Article.aspx?id=229</web_url>
    <pdf_url>https://www.ajmb.org/PDF/En/FullText/229.pdf</pdf_url>
	<author_list><author><first_name>Ali</first_name><middle_name></middle_name><last_name>Salimi</last_name><suffix></suffix><affiliation>Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>352</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Mohammad</first_name><middle_name></middle_name><last_name>Babashamsi</last_name><suffix></suffix><affiliation>Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>34</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

</articleset>
</journal>

